Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SUN CHEMICAL INKS A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.4% 11.5% 5.7% 5.0% 7.1% 6.0% 18.0% 18.0%   Credit score (0-100)   43 21 39 43 33 39 8 8   Credit rating   BBB BB BBB BBB BBB BBB B B   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   8,213 9,968 8,761 11,816 20,565 24,469 0.0 0.0   EBITDA   2,220 3,967 3,932 3,106 2,929 6,214 0.0 0.0   EBIT   2,220 3,967 3,932 3,106 2,929 6,214 0.0 0.0   Pre-tax profit (PTP)   1,574.0 3,116.0 3,254.0 2,054.0 1,348.0 4,613.0 0.0 0.0   Net earnings   5,703.0 3,116.0 7,336.0 1,596.0 1,049.0 3,594.0 0.0 0.0   Pre-tax profit without non-rec. items   1,574 3,116 3,254 2,054 1,348 4,613 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   698 442 171 87.0 47.0 322 0.0 0.0   Shareholders equity total   -37,903 -34,787 -27,451 -25,855 -24,806 -21,212 -23,412 -23,412   Interest-bearing liabilities   47,740 36,141 34,887 31,808 30,481 27,478 23,412 23,412   Balance sheet total (assets)   12,548 4,268 9,758 10,841 10,511 10,222 0.0 0.0   Net Debt   47,740 36,141 34,887 31,808 30,481 27,478 23,412 23,412     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   8,213 9,968 8,761 11,816 20,565 24,469 0.0 0.0   Gross profit growth   29.4% 21.4% -12.1% 34.9% 74.0% 19.0% -100.0% 0.0%   Employees   4 5 5 8 16 15 0 0   Employee growth %   0.0% 25.0% 0.0% 60.0% 100.0% -6.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   12,548 4,268 9,758 10,841 10,511 10,222 0 0   Balance sheet change%   27.0% -66.0% 128.6% 11.1% -3.0% -2.7% -100.0% 0.0%   Added value   2,220.0 3,967.0 3,932.0 3,106.0 2,929.0 6,214.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -100 -256 -271 -84 -40 275 -322 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   27.0% 39.8% 44.9% 26.3% 14.2% 25.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.3% 9.0% 10.4% 8.5% 8.2% 18.7% 0.0% 0.0%   ROI %   4.6% 9.6% 11.2% 9.4% 9.5% 21.5% 0.0% 0.0%   ROE %   50.9% 37.1% 104.6% 15.5% 9.8% 34.7% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   -75.1% -89.1% -73.8% -70.5% -70.2% -67.5% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   2,150.5% 911.0% 887.3% 1,024.1% 1,040.7% 442.2% 0.0% 0.0%   Gearing %   -126.0% -103.9% -127.1% -123.0% -122.9% -129.5% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.4% 2.1% 2.0% 3.3% 5.2% 5.6% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.3 0.2 0.4 0.5 0.6 0.8 0.0 0.0   Current Ratio   0.4 0.2 0.4 0.5 0.6 0.9 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -16,330.0 -12,721.0 -8,935.0 -6,800.0 -5,412.0 -1,074.0 -11,706.0 -11,706.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   555 793 786 388 183 414 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   555 793 786 388 183 414 0 0   EBIT / employee   555 793 786 388 183 414 0 0   Net earnings / employee   1,426 623 1,467 200 66 240 0 0